Medicare AI Prior Authorization Pilot Delaying Care in Washington: Report

Why It Matters

Prolonged AI‑based prior authorizations threaten patient outcomes and inflate provider expenses, challenging Medicare’s goal of cost‑effective care while sparking bipartisan scrutiny of the program’s efficacy.

Key Takeaways

• AI prior‑auth pilot extends approval time to 4‑8 weeks in Washington
• Providers add staff, raising administrative costs amid delayed care
• Virtix Health limits access, causing bottlenecks when staff absent
• Medicare aims to curb waste, but pilot may worsen outcomes

Pulse Analysis

The Wasteful and Inappropriate Service Reduction (WISeR) model was launched by CMS last year to harness artificial intelligence for prior authorization decisions, targeting services such as skin substitutes and epidural steroid injections. By outsourcing the review process to private firms, the program promised faster, data‑driven denials of low‑value care, aligning with broader federal efforts to trim Medicare spending. However, early data from Washington reveal a stark contrast between the model’s three‑day target for routine cases and the reality of four to eight weeks, exposing a gap between technological optimism and operational execution.

For clinicians on the front lines, the extended turnaround has translated into tangible workflow disruptions. The University of Washington Medical System reports an average 15‑20‑day wait for authorization, leaving nearly 100 patients in limbo for pain‑management injections. Hospitals have responded by hiring additional staff and extending work hours to manage the surge in paperwork, a cost that may ultimately be passed to patients and insurers. Moreover, Virtix Health’s policy of granting request‑status visibility only to the submitting employee creates bottlenecks when personnel are unavailable, compounding delays and eroding confidence in the AI system’s reliability.

The pilot’s challenges have ignited a policy debate that pits waste reduction against access to care. While HHS Secretary Robert F. Kennedy Jr. emphasizes the need to eliminate fraudulent spending on high‑cost procedures, senators like Maria Cantwell argue that the current implementation undermines the very seniors Medicare is meant to protect. As bipartisan pressure mounts, the future of AI‑driven prior authorizations will likely hinge on whether the program can reconcile efficiency gains with the imperative to deliver timely, patient‑centered treatment.